BAXALTA GMBH PATENTS FACING OPPOSITIONS
Top patents of BAXALTA GMBH facing oppositions at the European Patent Office (EPO)
| Patent Number | Grant Date | Patent Title | Expected Expiration Date | Facing Oppositions | Activity Alert |
|---|---|---|---|---|---|
| EP3277718B1 | 24 Mar, 2021 | Dosage Regimen For Anti-Mif Antibodies | Mar, 2036 | 1 | |
| EP3116534B1 | 29 May, 2019 | Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders | Mar, 2035 | 1 |